Cargando…

LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data

BACKGROUND: Somatic amplifications of the LYL1 gene are relatively common occurrences in patients who develop uterine corpus endometrial carcinoma (UCEC) as opposed to other cancers. This study was undertaken to determine whether such genetic alterations affect survival outcomes of UCEC. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Se Ik, Lee, Ji Won, Lee, Nara, Lee, Maria, Kim, Hee Seung, Chung, Hyun Hoon, Kim, Jae-Weon, Park, Noh Hyun, Song, Yong-Sang, Seo, Jeong-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930686/ https://www.ncbi.nlm.nih.gov/pubmed/29716549 http://dx.doi.org/10.1186/s12885-018-4429-z

Ejemplares similares

Prognostic role of computed tomography-based, artificial intelligence-driven waist skeletal muscle volume in uterine endometrial carcinoma
por: Kim, Se Ik, et al.
Publicado: (2021)

Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer
por: Kang, Seo Young, et al.
Publicado: (2017)

Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen
por: Jeon, Se Jeong, et al.
Publicado: (2017)

Lyl-1 regulates primitive macrophages and microglia development
por: Wang, Shoutang, et al.
Publicado: (2021)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
por: Kim, Se Ik, et al.
Publicado: (2019)

Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
por: Kim, Se Ik, et al.
Publicado: (2020)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

Ewing’s Sarcoma/Primitive Neuroectodermal Tumor of the Uterine Corpus
por: Lee, Eung-Seok, et al.
Publicado: (2015)

Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
por: Kim, Se Ik, et al.
Publicado: (2023)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
por: Kim, Se Ik, et al.
Publicado: (2022)

Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study
por: Lim, Hyunji, et al.
Publicado: (2022)

Lyl1 regulates lymphoid specification and maintenance of early T lineage progenitors
por: Zohren, Fabian, et al.
Publicado: (2012)

Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Lee, Shin-Wha, et al.
Publicado: (2017)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
por: Lin, Zhiheng, et al.
Publicado: (2022)

Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma
por: Yu, Cong, et al.
Publicado: (2022)

Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation
por: Yuan, Yi, et al.
Publicado: (2021)

Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
por: Kim, Se Ik, et al.
Publicado: (2020)

Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy
por: Kim, Se Ik, et al.
Publicado: (2021)

Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)

Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2019)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
por: Jagodzińska, Anna, et al.
Publicado: (2023)

Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2023)

Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer
por: Chung, Hyun Hoon, et al.
Publicado: (2016)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma?
por: Song, Changho, et al.
Publicado: (2023)

A randomized prospective trial of the postoperative quality of life between laparoscopic uterine artery ligation and laparoscopy-assisted vaginal hysterectomy for the treatment of symptomatic uterine fibroids: clinical trial design
por: Kim, Hee Seung, et al.
Publicado: (2009)

Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes
por: Sohn, Min-Hwan, et al.
Publicado: (2021)

Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
por: Seol, Aeran, et al.
Publicado: (2022)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
por: Li, Dong, et al.
Publicado: (2021)

Erratum: Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2021)

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma
por: Zhao, Ling, et al.
Publicado: (2021)

Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma
por: Wang, Min, et al.
Publicado: (2023)

Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis
por: Li, Haixia, et al.
Publicado: (2023)

Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma
por: Song, Siyuan, et al.
Publicado: (2023)

Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer
por: Kim, Se Ik, et al.
Publicado: (2021)

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
por: Kim, Se Ik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2krildcq5njbfva2mo30hrehcu